The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksKIT.L Regulatory News (KIT)

  • There is currently no data for KIT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Research: Kepler Trust Intelligence

14 Nov 2018 07:00

RNS Number : 1989H
Keystone Investment Trust Plc
14 November 2018
 

Keystone Investment Trust: New research

14/11/18

Highlights:

· New manager James Goldstone is nearing the completion of the portfolio's transition since taking over in April 2017

· James employs a value-based approach to pick stocks with dividend policy a focus, resulting in a higher yield than the typical growth fund

· Portfolio is primarily UK-focused, but limited international exposure helps hedge the exposure to UK earnings

· The trust has remained on a stubbornly wide discount, at least partly due to uncertainty around the macro backdrop

 

Read more

 

Keystone invests mainly in UK companies, aiming to maximise total return through a value-based strategy focused on cash flow and dividends.

The new manager, James Goldstone, has largely completed the transition of the portfolio he took over in April 2017, which has seen the trust maintain its thematic exposure to undervalued UK earnings, but take up new positions in the banking sector among others and sell down its tobacco and healthcare exposure.

James has also hedged the core exposure to UK earnings with dollar earners and growth companies that he believes more than justify their current multiples.

The trust languishes on one of the widest discounts in the sector at 11%, largely due to UK domestic earners being out of favour and the board not buying back shares in recent years.

Dividends are a key ingredient to the stock selection process, and the trust yields 3.4%, not far off the 3.9% average for a UK Equity Income fund, although it sits in the UK All Companies sector.

Click here to read the full report

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Important information

Keystone Investment Trust is a client of Kepler Trust Intelligence. This material should be considered a marketing communication, and is not independent research.

Kepler Partners is not authorised to make recommendations to Retail Clients. This report is based on factual information only, and is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

This report has been issued by Kepler Partners LLP solely for information purposes only and the views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment. If you are unclear about any of the information on this website or its suitability for you, please contact your financial or tax adviser, or an independent financial or tax adviser before making any investment or financial decisions.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. Persons who access this information are required to inform themselves and to comply with any such restrictions. In particular, this website is exclusively for non-US Persons. The information in this website is not for distribution to and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States of America to or for the benefit of US Persons.

This is a marketing document, should be considered non-independent research and is subject to the rules in COBS 12.3 relating to such research. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research.

No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not to be taken as advice to take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's conflict of interest policy is available on request.

Past performance is not necessarily a guide to the future. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that Independent financial advice should be taken before entering into any financial transaction.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is a limited liability partnership registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority.

 

 

About this service

Kepler Trust Intelligence for private investors is not just another news and research website. Our aim is to create a library of high quality investment strategy research, fund analysis and useful guides for private investors, all written in-house by experienced analysts on the investment companies team at Kepler Partners.

We are focused entirely on investment trusts, however we believe that it helps to understand them better if they are placed on a level playing field with OEICs, so you will see comparisons between the two in these pages often.

 

Our content falls into three categories;

Investment strategy articles are designed to highlight opportunities and developments which are of interest to investment trust investors, positive or negative.

Fund research focuses on individual trusts, examining them in detail to create a snapshot picture which you can use to decide whether or not you want to invest in them.

Educational output is split into simple guides, designed to help beginners understand how investment trusts work, and more complex guides to sectors, regions and strategies which may be of interest to investors.

We do not produce massive amounts of research. Our focus is on quality, not quantity, so we are unlikely to publish more than four or five articles in a given week. For this reason we recommend that you join our mailing list, and we'll send you an email once a week alerting you to what's new on the site. We won't sell your details, and we won't spam you with useless updates.

 

How are we funded?

Kepler Trust Intelligence is funded entirely by the providers of investment trusts, and is made available freely to any person (professional or private individual) who wants to access it. We clearly disclose all of our relationships, but our research is either paid for directly by specific trusts and their boards, or more generally by the larger asset management groups who pay to have adverts and advertorial. As a result, all of our research should be considered "non-independent" and readers should consider it as marketing.

All of our content is freely available to anyone. We run two versions of the site - one for professionals and one for private investors. The professional site requires readers to volunteer the name of the company they work for and the city / region - so that from a compliance perspective we can be satisfied that all readers really are a professional.

 

We provide information, not advice

While we hope that you find the research we publish useful, and we believe it will help you to make a more informed decision, but we must of course stress that none of the research published here constitutes a recommendation, or advice, and you should not think that - just because we've published a report on a trust - we believe that trust is a 'buy'. Please read our terms and conditions.

 

If you want to manage your own investments we hope that this website is a useful source of information which helps you to do that, however if you are in any doubt, you should speak to a financial adviser.

 

Pascal Dowling

 

Kepler Partners

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRALLFEILDLVLIT
Date   Source Headline
15th Jan 20202:00 pmPRNNet Asset Value(s)
14th Jan 20205:22 pmPRNTransaction in Own Shares
14th Jan 202011:36 amPRNNet Asset Value(s)
13th Jan 202011:55 amPRNDirector/PDMR Shareholding
13th Jan 202011:49 amPRNNet Asset Value(s)
10th Jan 20205:13 pmPRNTransaction in Own Shares
10th Jan 202012:17 pmPRNNet Asset Value(s)
9th Jan 20205:05 pmPRNTransaction in Own Shares
9th Jan 202011:59 amPRNNet Asset Value(s)
9th Jan 20209:18 amPRNTransaction in Own Shares - Correction
8th Jan 20205:04 pmPRNHolding(s) in Company
8th Jan 20204:52 pmPRNTransaction in Own Shares
8th Jan 202011:27 amPRNNet Asset Value(s)
7th Jan 202011:41 amPRNNet Asset Value(s)
6th Jan 20204:48 pmPRNTransaction in Own Shares
6th Jan 202012:29 pmPRNNet Asset Value(s)
3rd Jan 20205:15 pmPRNTransaction in Own Shares
3rd Jan 202011:59 amPRNNet Asset Value(s)
2nd Jan 20205:19 pmPRNTransaction in Own Shares
2nd Jan 20201:31 pmPRNTotal Voting Rights
2nd Jan 202011:36 amPRNNet Asset Value(s)
31st Dec 201912:01 pmPRNNet Asset Value(s)
30th Dec 20195:02 pmPRNTransaction in Own Shares
30th Dec 201911:34 amPRNNet Asset Value(s)
30th Dec 20197:00 amPRNTransaction in Own Shares
27th Dec 201912:07 pmPRNNet Asset Value(s)
27th Dec 20199:39 amPRNHolding(s) in Company
24th Dec 20191:03 pmPRNTransaction in Own Shares
24th Dec 201911:35 amPRNNet Asset Value(s)
23rd Dec 201912:03 pmPRNNet Asset Value(s)
23rd Dec 201911:40 amPRNHolding(s) in Company
23rd Dec 20197:00 amPRNStatement re proposed share buy-back
20th Dec 201912:18 pmPRNNet Asset Value(s)
19th Dec 201911:50 amPRNNet Asset Value(s)
18th Dec 20192:59 pmPRNHolding(s) in Company
18th Dec 201911:17 amPRNNet Asset Value(s)
17th Dec 20191:11 pmPRNNet Asset Value(s)
16th Dec 201911:44 amPRNNet Asset Value(s)
13th Dec 201911:42 amPRNNet Asset Value(s)
12th Dec 201911:42 amPRNNet Asset Value(s)
11th Dec 201911:44 amPRNNet Asset Value(s)
10th Dec 201911:46 amPRNNet Asset Value(s)
9th Dec 201911:25 amPRNNet Asset Value(s)
6th Dec 201911:28 amPRNNet Asset Value(s)
5th Dec 201911:30 amPRNNet Asset Value(s)
4th Dec 201911:55 amPRNNet Asset Value(s)
3rd Dec 201911:49 amPRNNet Asset Value(s)
2nd Dec 20192:57 pmPRNPortfolio Update
2nd Dec 201912:28 pmPRNNet Asset Value(s)
2nd Dec 201911:00 amPRNAnnual Financial Report on NSM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.